Eye Diseases
Conditions
Interventions
Zithromax by Pfizer Administration
Cenzo Administration
Sponsors
Royal Society of Tropical Medicine and Hygiene
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Children aged 1 to 9 years at the time of recruitment. 2. Children residing within Ogwuagor, Abakpa Nike, Urban slum, Enugu State. 3. Children clinically diagnosed with Chlamydia Trachomatis (CT) Infection. 4. Children whose parents or legal guardians demonstrated voluntary participation by informed consent.
Exclusion criteria
Exclusion criteria: 1. Children outside the age range (below one year old, and above 9 years old). 2. Children with known allergies or contraindications to the brands of azithromycin used in the trial 3. Children with severe co-morbidities that could confound outcome assessment or make their participation unsafe (e.g., severe malnutrition, or chronic debilitating illness) 4. Children whose parents or legal guardians refused to provide consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to relapse of Chlamydia Trachomatis - CT infection after initial antibiotic treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of the mean or the median time to relapse between the groups ;Incidence of relapse for each treatment group and its impact on the relapse status.;Significant impact of gender on the time to relapse;The significant impact of WASH on the time of relapse | — |
Countries
Nigeria
Contacts
Public ContactOliver Ogbonna
Senior Lecturer Department of Economics University of Nigeria Nsukka.
Outcome results
None listed